Effect of cancer cachexia on the outcomes of first-line chemotherapy in pancreatic cancer: A claims database study

被引：0
|
作者：
Furuse, Junji [1 ]
Osugi, Fumihiko [2 ]
Machii, Koji [2 ]
Niibe, Koji [2 ]
Endo, Toshimitsu [2 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[2] Ono Pharmaceut Co Ltd, Ono, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO61-3
引用
收藏
页码：S1435 / S1435
页数：1
相关论文
共 50 条
  • [31] Updated use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine
    Cartwright, Thomas H.
    Arlen, Aimee Ginsburg
    Wilfong, Lalan S.
    Harrell, Robyn K.
    Hoverman, J. Russell
    Beveridge, Roy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Beyond first-line chemotherapy for advanced pancreatic cancer: An expanding array of therapeutic options?
    Walker, Evan J.
    Ko, Andrew H.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (09) : 2224 - 2236
  • [33] Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy
    Kim, Seung Tae
    Lim, Do Hyoung
    Jang, Kee-Taek
    Lim, Taekyu
    Lee, Jeeyun
    Choi, Yoon-La
    Jang, Hye-Lim
    Yi, Jun Ho
    Baek, Kyung Kee
    Park, Se Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Joon Oh
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (10) : 1993 - 1999
  • [34] Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancer
    Xifeng Xu
    Qiong Wu
    Zhen Wang
    Song Zheng
    Ke Ge
    Changku Jia
    Clinical and Experimental Medicine, 2019, 19 : 149 - 157
  • [35] Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancer
    Xu, Xifeng
    Wu, Qiong
    Wang, Zhen
    Zheng, Song
    Ge, Ke
    Jia, Changku
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (01) : 149 - 157
  • [36] DURATION OF FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    Gennari, Alessandra
    Provinciali, Nicoletta
    BREAST, 2015, 24 : S31 - S31
  • [37] The integration of docetaxel into first-line chemotherapy for ovarian cancer
    Kaye, SB
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 : 31 - 33
  • [38] First-line chemotherapy for ovarian cancer – the controversy continues
    S B Kaye
    British Journal of Cancer, 2002, 87 : 813 - 814
  • [39] First-line chemotherapy for ovarian cancer - the controversy continues
    Kaye, SB
    BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 813 - 814
  • [40] Intraarterial chemotherapy as the first-line therapy in penile cancer
    P-H Chiang
    C-H Chen
    Y-C Shen
    British Journal of Cancer, 2014, 111 : 1089 - 1094
12345